Scientific Presentations and Posters
Annual Cochrane Colloquia are held to promote and develop the work of the Collaboration, and to help shape its future direction. For workshops at Cochrane Colloquia see our webpage on workshops and meetings. Many oral and poster presentations at past colloquia have been related to the methodologies of incorporating adverse effects into systematic reviews:
24th Cochrane Colloquium 2016
Golder S. Loke YK, Wright K, Sterrantino C. Are unpublished data included in systematic reviews? A survey of 348 reviews of adverse effects. 24th Cochrane Colloquium, Seoul, South Korea, 23-27 October 2016.
Golder S, Loke Y, Wright K, Norman G. The extent of hidden or unpublished adverse events data: A methodological review. 24th Cochrane Colloquium, Seoul, South Korea, 23-27 October 2016.
23rd Cochrane Colloquium 2015
Golder S, Junqueira D, Zorzela L. Adverse effects in systematic reviews: challenges for formulating the question and searching for different studies and sources of information. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Zorzela L, Golder S, Junqueira D. Reporting adverse events in reviews and the PRISMA Harms. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Junqueira D, Golder S, Zorzela L. Terminology challenges for data extraction and analysis of data on adverse effects. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Golder S, Norman G, Loke Y. Systematic review on social media as a data source for information on adverse effects. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Junqueira D, Lana L, Menezes de Pádua C, Zorzela L, Vohra S. (2015). Bias in measurement of adverse outcomes in non-randomised studies. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Junqueira D, Faria J, Fontoura M, Menezes de Pádua C. (2015). Inconsistent evaluation of heparin-induced thrombocytopenia in Cochrane systematic reviews: are harm-benefit balance truly being appraised?. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Junqueira D, Lana L, Fontoura M, Perini E, Menezes de Pádua C. (2015). Estimating the occurrence of non-standardised adverse outcomes: the case of lipodystrophy. 23rd Cochrane Colloquium, Vienna, Austria, 3-7 October 2015.
Junqueira D. (2015). Moving from research to practice: training students with abilities to translate and communicate evidence. 23rd Cochrane Colloquium. Vienna, Austria, 3-7 October 2015.
21st Cochrane Colloquium 2013
Golder S, Herxheimer A, Loke Y, Vohra S. Welcome to the Cochrane Adverse Effects Methods Group. 21st Cochrane Colloquium, Quebec, Canada, September 2013
Zorzela L, Moher D, Vohra S. Development of the PRISMA Harms Extension. 21st Cochrane Colloquium, Quebec, Canada, September 2013
Golder S, Loke Y, Bland M. Methodological Overview: Meta-analyses of Adverse Effects Data from Case-Control Studies as Compared to Other Observational Studies. 21st Cochrane Colloquium, Quebec, Canada, September 2013
Dryden D, Sumamo Schellenberg E, Vandermeer B, Rowe B. A novel approach to presenting adverse effect results: a case study. 21st Cochrane Colloquium, Quebec, Canada, September 2013
Junqueira DRG, Ferreira ML, Pinto RZ, Candido RCF, How rare are adverse drug effects? Assessing the frequency of harm effects of drug treatments for the management of sciatica in primary care. 21st Cochrane Colloquium, Quebec, Canada, September 2013
Saini P, Gamble C, Loke Y, Altman DG, Williamson P, Kirkham JJ. Understanding the process and impact of within-study selective reporting bias for harm outcomes (ORBIT II – Outcome Reporting Bias in Trials). 21st Cochrane Colloquium, Quebec, Canada, September 2013
Furlan A, Irvin E, Carnide N, Munhall C, Loke Y, Marin T.
19th Cochrane Colloquium 2011
Acuin J. Assessment of hospital capacities in patient safety in the Philippines. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Gaitán Duarte H, Vallejo Ortega MT, García Dieguez M, Esandi ME, de Luca M, Milberg M, Cho M, Monserrat - Capella D, Reveiz L. Instruments and methodologies used for detecting and characterizing adverse events in ambulatory care: a systematic review. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Golder S, Loke Y. The sensitivity and precision of adverse effects search filters in MEDLINE, EMBASE and Science Citation Index (SCI). 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Golder S, Loke Y. The usefulness of different information sources for retrieving adverse effects data for a systematic review. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Golder S, Loke Y, Bland M. Comparison of adverse effects data derived from different study designs. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Harris J. Evidence to support patient safety improvement. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Junqueira DRG, Carvalho MDG, Perini E. Using systematic reviews to study adverse drug reactions: the example of heparin-induced thrombocytopenia. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Kirkham J. An investigation into the assessment and reporting of harms in clinical studies. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Lauvrak V, Norderhaug IN, Saunes IS, Krogstad U. Evidence evaluation in ranking target areas of interest for a national patient safety campaign. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Leiknes KA, Høie B, Jarosch-von Schweder L, Berg R, Smedslund G. Long-term harm and memory impairment in electroconvulsive therapy treatment for depression – preliminary results from a systematic review with integrative methodological approach. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
López-Arrieta JM. Syncope and other adverse events associated with Cholinesterase Inhibitors: Systematic Review of the literature vs analysis of the FDA Adverse Events Database. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Mejia HM. Six sigma applications for patient safety in a university hospital. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Melnik T, Soares B, Puga E, Atallah A, Rufino C. Efficacy and safety of atypical antipsychotic drugs (quetiapine, risperidone, aripiprazole and paliperidone) compared with placebo or typical antipsychotic drugs for treating refractory
schizophrenia: overview of systematic reviews. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
schizophrenia: overview of systematic reviews. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Ntzani E. Warnings for serious adverse events in drug labelling: are same-class drugs treated the same? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Perez S, Rodriguez V, Cattivera C, Pardo J, García Elorrio E. Knowledge translation in patient safety: what barriers
are present to asses the evidence in practitioners? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
are present to asses the evidence in practitioners? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Pilkington K, Boshnakova A. Where and how to find data on safety: what do systematic reviews
of complementary therapies tell us? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
of complementary therapies tell us? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Santaguida P, Keshavarz H, MacQueen G, Levine M, Beyene J, Raina P. Development of the McHarm: A tool evaluating validity of the collection and reporting of harms. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Shaw K, Rickard S, Reay T, Thomson D. The building blocks of safety: creating multi-disciplinary micro-systems and departmental PSOs as the foundation for a successful patient safety program. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Thomson D, Seto I, Scanlon M. Safe care for children: a scoping review of what we know, and what we need to find out. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Thomson D, Matlow A, Rickard S, Scanlon M, Williams K. Paediatric patient safety: the distinctive nature of childhood must be part of the equation. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Tudur-Smith C, Marson A. Adverse events of antiepileptic drugs, across indications: Can randomised controlled trial data from non-epilepsy indications be included in meta-analysis for AEDs used in epilepsy? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Zhang Q, Li Y, Zhang L, Yin Q, Shang L, Wei X, Zhang M. A survey analysis of patient for patient safety in China. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Zhang Q, Zhang M. Patient for patient safety research in Cochrane Library. 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
Zorzela L, Punja S, Joffe A, Hartling L, Loke Y, Vohra S. Systematic Reviews of Adverse Events. Is Screening by Title and Abstract Enough? 19th Cochrane Colloquium, Madrid, Spain, 19-22 October 2011
17th Cochrane Colloquium 2009
Mhaskar R, Kumar A, Soares H, Gardner B, Djulbegovic B. Treatment related harms: what was planned and what was reported? An analysis of Southwest Oncology Group phase III trials. 17th Cochrane Colloquium, Singapore, 11-14 October 2009
Wieseler B, Vervölgyi V, Kaiser T. Evaluation of harms in HTAs and systematic reviews of drug interventions. 17th Cochrane Colloquium, Singapore, 11-14 October 2009
16th Cochrane Colloquium 2008
Biester K, Skipka G, Lange S. Interpreting intergroup differences on low quality data of adverse events (AE) in primary clinical trials of non-drug interventions. 16th Cochrane Colloquium, Freiburg, Germany, 3-7 October 2008.
Chen XY, Fan ZY, Zhou Y, Dong XX, Liu Y, Wan XL,Wang F, QW Zhang QW. Clinician’s basic knowledge on patient safety in China. 16th Cochrane Colloquium, Freiburg, Germany, 3-7 October 2008.
Golder S, Loke YK, Burch, J. Impact of funding source on reporting of adverse effects: methodological overview. 16th Cochrane Colloquium, Freiburg, Germany, 3-7 October 2008.
Golder S, Loke YK, Burch J. Where to identify information on adverse effects for a systematic review: a methodological overview. 16th Cochrane Colloquium, Freiburg, Germany, 3-7 October 2008.
Riera R, Vieira VP, Andriolo RB, Lima LG, Macedo CR, Puga MES, Silva BN, Atallah AN. Information concerning the safety and adverse effects of medical procedures reported in a Brazilian journal 16th Cochrane Colloquium, Freiburg, Germany, 3-7 October 2008.
Vandenbroucke JP. Balancing benefits and risks of treatment: combining the best evidence on benefit with the best evidence about harms. 16th Cochrane Colloquium, Freiburg, Germany, 3-7 October 2008.
15th Cochrane Colloquium 2007
Ai C, Zhang M, Li J. Adverse effects of traditional chinese medicine should be reported in Cochrane reviews.15th Cochrane Colloquium, Sao Paulo, Brazi, 23-27 October 2007.
Bastian H, Schultheis A. Good news about bad news: Improvements in attention to adverse effects in Cochrane reviews (1997-2007).15th Cochrane Colloquium, Sao Paulo, Brazi, 23-27 October 2007.
Kovacs Burns K, Lyddiatt A. From gloabl to local patient safety champions: collaborating on improving patient safety. 15th Cochrane Colloquium, Sao Paulo, Brazi, 23-27 October 2007.
Reeves BC, Herxheimer A, Wells GA, Gyte G. Describing rare and serious harms of interventions. 15th Cochrane Colloquium, Sao Paulo, Brazil 23-27 October 2007.
Reeves BC, Herxheimer A, Wells GA, Gyte G. Describing rare and serious harms of interventions. 15th Cochrane Colloquium, Sao Paulo, Brazil 23-27 October 2007.
14th Cochrane Colloquium 2006
Aronson J, Hauben M. Between-the-eyes adverse drug reactions: anecdotes as evidential gold standards. 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
Bastian H, Herxheimer A, Wieseler B. What are the characteristics of good reviews of adverse effects? A qualitative exploration 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
Golder S, Loke Y, McIntosh H. How is information on adverse effects identified for systematic reviews? A survey of methods used from 1994-2005. 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
Golder S, Loke Y, McIntosh H. Going beyond MEDLINE - what information might reviewers find from searching databases of adverse drug reactions. 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
Hopewell S, Wolfenden L, Clarke M. Reporting of adverse events in systematic reviews. 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
Juhl Jørgensen K. Author affiliation influences the presentation of benefits and harms of mammography screening in scientific articles. 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
Scherer R. Are harms reported in abstracts of trial results from conference proceedings? 14th Cochrane Colloquium, Dublin, Ireland, 23-26 October 2006.
13th Cochrane Colloquium 2005
Ethgen M, Boutron I, Baron G, Giraudeau B, Sibilia J, Ravaud P. Reporting of harm in randomized controlled trials evaluating pharmacological and nonpharmacological treatments. 13th Cochrane Colloquium, Melbourne, Australia, 22-26 October 2005.
Golder S, McIntosh H, Glanville J. Searching for systematic reviews of adverse effects. 13th Cochrane Colloquium, Melbourne, Australia, 22-26 October 2005.
12th Cochrane Colloquium 2004
Golder S, Duffy S, Glanville J, McIntosh H. Developing efficient search strategies to identify papers on adverse events. B: using statistical analysis. 12th Cochrane Colloquium Ottawa, Ontario, Canada, 2-6 October 2004.
Golder S, Duffy S, Glanville J, McIntosh H, Miles J. Developing efficient search strategies to identify papers on adverse events. A: testing precision and sensitivity.12th Cochrane Colloquium Ottawa, Ontario, Canada, 2-6 October 2004.
Jefferson T, Demicheli V. Including non-randomised studies in systematic reviews of vaccines safety: methodological issues. 12th Cochrane Colloquium Ottawa, Ontario, Canada, 2-6 October 2004.
Papanikolaou P, Churchill R, Wahlbeck K, Ioannidis J. Reporting of harms in randomized trials of mental health interventions. 12th Cochrane Colloquium Ottawa, Ontario, Canada, 2-6 October 2004.
Papanikolaou P, Ioannidis J. Availability of large-scale evidence on specific harms from systematic reviews of randomised trials.12th Cochrane Colloquium Ottawa, Ontario, Canada, 2-6 October 2004.
Vandermeer B, Wiebe N, Buscemi N, Hartling L, Klassen T. Adverse events and adverse effects in systematic reviews: some methodological issues. 12th Cochrane Colloquium Ottawa, Ontario, Canada, 2-6 October 2004.
11th Cochrane Colloquium 2003
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and authors' conclusions in randomized drug trials: a reflection of treatment benefit or adverse events? 11th Cochrane Colloquium, Barcelona, Spain, 26-31 October 2003.
Clarke A, Shakir S, Deeks J. ''Withdrawn from market'' - how comprehensive and accessible is the evidence-base for medicinal products withdrawn due to safety concern? 11th Cochrane Colloquium, Barcelona, Spain, 26-31 October 2003.
Jefferson T, Demicheli V, Bianco E. The handling of evidence in systematic reviews of vaccines safety: methodological issues. 11th Cochrane Colloquium, Barcelona, Spain, 26-31 October 2003.
MacLehose HG, Klaes D, Garner P. What methods do trials use to collect adverse data? 11th Cochrane Colloquium, Barcelona, Spain, 26-31 October 2003.
MacLehose, H.G. ; Klaes, D. ; Garner, P. Overcoming difficulties with extracting adverse event data.11th Cochrane Colloquium, Barcelona, Spain, 26-31 October 2003.
9th Annual Cochrane Colloquium 2001
Ioannidis JPA, Chew P, Lau J. Standardized retrieval of side effects data for meta-analysis: a feasibility study in acute sinusitis. 9th Annual Cochrane Colloquium, Lyon, France, October 2001.
Loke YK, Derry S. Lack of detail and uniformity in the reporting of adverse drug reactions in randomized controlled trials: important implications for systematic reviews. 9th Annual Cochrane Colloquium, Lyon, France, October 2001.
Smith LA, Deeks JJ. Should case-control studies be included in systematic reviews of the effects of healthcare interventions? 9th Annual Cochrane Colloquium, Lyon, France, October 2001.
Zhang WY. Evidence from case-control and cohort studies for adverse drug reaction - a case study of analgesic nephropathy. 9th Annual Cochrane Colloquium, Lyon, France, October 2001.
8th Annual Cochrane Colloquium 2000
Cosmi B, Castelvetri C, Milandri M, Rubboli A, Confoti A. The evaluation of rare adverse drug events in Cochrane reviews: the incidence of thrombotic thrombocytopenic purpura after ticlopidine plus aspirin for coronary stenting. 8th Annual Cochrane Colloquium, Cape Town, South Africa, October 2000.
Craig J, Irwig L. Evaluating both benefits and harms of interventions: the need for equality. 8th Annual Cochrane Colloquium, Cape Town, South Africa, October 2000.
Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin Chemoprophylaxis: Weighing the benefits and harms for patients at different levels Of risk for cardiovascular disease. 8th Annual Cochrane Colloquium, Cape Town, South Africa, October 2000.
Li Wan Po A, Herxheimer A, Poolsup N, Aziz Z. How do Cochrane reviewers address adverse effects of drug therapy? 8th Annual Cochrane Colloquium, Cape Town, South Africa, October 2000.
7th Annual Cochrane Colloquium 1999
Badgett R, Chiquette E, Anagnostelis B, Mulrow C. Locating reports of serious adverse drug reactions. 7th Annual Cochrane Colloquium, Rome, October 1999.
Croft A, Garner P. Travelling to the tropics? How to enrich a systematic review with good observational evidence about adverse effects. 7th Annual Cochrane Colloquium, Rome, October 1999.
Loke YK, Edwards J, Deny S. Conventional search strategies cannot easily identify those trials of drug therapy which provide quantitative adverse effects data. 7th Annual Cochrane Colloquium, Rome, October 1999.
6th Annual Cochrane Colloquium 1998
Edwards JE, McQuay HJ, Moore RA, Collins SL. Guidelines for reporting adverse effects in clinical trials should be improved - lessons from acute pain. 6th Annual Cochrane Colloquium, Baltimore, MD, USA. 22-26 October 1998.
2nd International Conference Scientific Basis of Health Services & 5th Annual Cochrane Colloquium 1997
Bastian H, Middleton P. More good than harm: how well can Cochrane Reviews help people decide? 2nd International Conference Scientific Basis of Health Services & 5th Annual Cochrane Colloquium, Amsterdam, The Netherlands, 8-12 October 1997.